India
· Delayed Price · Currency is INR Ajanta Pharma Statistics
Total Valuation
Ajanta Pharma has a market cap or net worth of INR 419.97 billion. The enterprise value is 415.74 billion.
| Market Cap | 419.97B |
| Enterprise Value | 415.74B |
Important Dates
The next estimated earnings date is Thursday, October 31, 2024.
| Earnings Date | Oct 31, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Ajanta Pharma has 125.35 million shares outstanding. The number of shares has decreased by -1.24% in one year.
| Shares Outstanding | 125.35M |
| Shares Change (YoY) | -1.24% |
| Shares Change (QoQ) | -0.12% |
| Owned by Insiders (%) | 53.42% |
| Owned by Institutions (%) | 23.57% |
| Float | 42.31M |
Valuation Ratios
The trailing PE ratio is 49.44 and the forward PE ratio is 41.98. Ajanta Pharma's PEG ratio is 3.23.
| PE Ratio | 49.44 |
| Forward PE | 41.98 |
| PS Ratio | 9.73 |
| PB Ratio | 11.90 |
| P/FCF Ratio | n/a |
| PEG Ratio | 3.23 |
Enterprise Valuation
| EV / Earnings | 48.69 |
| EV / Sales | 9.60 |
| EV / EBITDA | 33.66 |
| EV / EBIT | 37.66 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 1.03 |
| Debt / EBITDA | 0.03 |
| Debt / FCF | n/a |
| Interest Coverage | 155.70 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | 19.62% |
| Revenue Per Employee | 5.37M |
| Profits Per Employee | 1.06M |
| Employee Count | 8,073 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +92.59% in the last 52 weeks. The beta is 0.11, so Ajanta Pharma's price volatility has been lower than the market average.
| Beta (5Y) | 0.11 |
| 52-Week Price Change | +92.59% |
| 50-Day Moving Average | 2,697.18 |
| 200-Day Moving Average | 2,307.20 |
| Relative Strength Index (RSI) | 71.95 |
| Average Volume (20 Days) | 239,419 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Ajanta Pharma had revenue of INR 43.33 billion and earned 8.54 billion in profits. Earnings per share was 67.77.
| Revenue | 43.33B |
| Gross Profit | 31.96B |
| Operating Income | 11.04B |
| Pretax Income | 11.67B |
| Net Income | 8.54B |
| EBITDA | 12.23B |
| EBIT | 11.04B |
| Earnings Per Share (EPS) | 67.77 |
Balance Sheet
The company has 4.60 billion in cash and 368.40 million in debt, giving a net cash position of 4.23 billion or 33.72 per share.
| Cash & Cash Equivalents | 4.60B |
| Total Debt | 368.40M |
| Net Cash | 4.23B |
| Net Cash Per Share | 33.72 |
| Equity (Book Value) | 35.67B |
| Book Value Per Share | 281.60 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 73.76%, with operating and profit margins of 25.48% and 19.71%.
| Gross Margin | 73.76% |
| Operating Margin | 25.48% |
| Pretax Margin | 26.94% |
| Profit Margin | 19.71% |
| EBITDA Margin | 28.22% |
| EBIT Margin | 25.48% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 36.00, which amounts to a dividend yield of 1.07%.
| Dividend Per Share | 36.00 |
| Dividend Yield | 1.07% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 2 |
| Payout Ratio | n/a |
| Buyback Yield | 1.24% |
| Shareholder Yield | 2.31% |
| Earnings Yield | 2.02% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on June 22, 2022. It was a forward split with a ratio of 1.5.
| Last Split Date | Jun 22, 2022 |
| Split Type | Forward |
| Split Ratio | 1.5 |